article · EMJ Oncology
Pseudomyogenic hemangioendothelioma is an uncommon vascular neoplasm that has recently been identified as a distinct entity. Despite being classified as a malignant tumour and its often-worrisome clinical presentation, the progression typically involves relapses after surgery and a rather infrequent potential for metastasis. The authors present the clinical case of a pseudomyogenic hemangioendothelioma of the lower limb, its evolution to lymph node involvement and distant metastasis, and the effectiveness of vinorelbine in its management. Through this case report, the authors underscore the significance of a precise histological and immunohistochemical assessment considering the usual misdiagnosis as sarcoma or metaplastic carcinoma. They also emphasise the significance of observing the evolutionary aspects of this indolent tumour while outlining the therapeutic strategy and systemic therapies’ sequences to enhance the quality of life for these long survivors.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.33590/emjoncol/erte7664
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.